
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[BDTX] Black Diamond Therapeutics Inc - EBITDA / Share
Data updated 2023-Jun-24 (Saturday)Note: Detailed Statistics for EBITDA / Share in Income Statement for Black Diamond Therapeutics Inc [NASDAQ:BDTX] with frequency distribution chart that analyze trends & history . EBITDA per share is a valuation metric calculated as EBITDA / Shares Outstanding. View Income Statement for broader context
Share
Quarterly EBITDA / Share values for Black Diamond Therapeutics Inc are rounded to enhance readability
2023-Mar | 2022-Dec | 2022-Sep | 2022-Jun | 2022-Mar | 2021-Dec | |
---|---|---|---|---|---|---|
EBITDA / Share | -0.57 | -0.58 | -0.59 | -0.62 | -0.69 | -0.7 |
Sequential Quarter Growth | +1.7% | +1.7% | +4.8% | +10.1% | +1.4% | +27.1% |
Quarter-on Quarter Growth | +17.4% | +17.1% | +38.5% | +34.7% | +17.9% | -9.4% |
Annual EBITDA / Share values for Black Diamond Therapeutics Inc are rounded to enhance readability
2022-Dec | 2021-Dec | 2021-Jan | 2020-Jan | 2019-Jan | 2018-Jan | |
---|---|---|---|---|---|---|
EBITDA / Share | -2.47 | -3.44 | -3.44 | -2.1 | -0.82 | -0.25 |
Year-on-Year Growth | +28.2% | 0.0% | -63.8% | -156.1% | -228.0% | |
2-yr CAGR | ||||||
3-yr CAGR | ||||||
4-yr CAGR | ||||||
5-yr CAGR |
Frequency distribution of quarterly EBITDA / Share values from 2018-Dec-31 grouped into buckets. Latest EBITDA / Share value is -0.57 as of 2023-Mar-31
Subsequent stock performance post earnings date till next announcement for Black Diamond Therapeutics Inc mapped with quarterly EBITDA / Share values reported at that time. Most recent value denoted with star
Select frequency and calculation type for EBITDA / Share above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Black Diamond Therapeutics Inc with subsequent post-earnings performance given EBITDA / Share values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
EBITDA / Share - Low | 64% | 36% |
EBITDA / Share - Medium | 54% | 46% |
EBITDA / Share - High | 54% | 46% |
EBITDA / Share (Sequential growth %) - Low | 64% | 36% |
EBITDA / Share (Sequential growth %) - Medium | 28% | 72% |
EBITDA / Share (Sequential growth %) - High | 78% | 22% |
EBITDA / Share (QoQ growth %) - Low | 64% | 36% |
EBITDA / Share (QoQ growth %) - Medium | 54% | 46% |
EBITDA / Share (QoQ growth %) - High | 54% | 46% |
Related to Black Diamond Therapeutics Inc
Information for Black Diamond Therapeutics Inc
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Mar-14 on Google
SEC Reports : Quarterly reports around 2025-Mar-14 on SEC Edgar
Compare Black Diamond Therapeutics Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Black Diamond Therapeutics Inc
Industry : Biotechnology industry performance which includes Black Diamond Therapeutics Inc